marijuana stocks news

 


17-Nov-2015

Results of Operations and Financial Condition, Regulation FD Disclosure

Item 2.02 Results of Operations and Financial ConditionThe information provided below in “Item 7.01- Regulation FD Disclosure” of this Current Report on Form 8-K is incorporated by reference into this Item 2.02.

 

Item 7.01 Regulation FD DisclosureOn November 17, 2015, CannaVEST Corp. (the “Company”) announced the release of its Third Quarter 2015 earnings. A copy of the press release issued by the Company announcing the release of Third Quarter 2015 earnings is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information set forth under this Item 7.01, including Exhibit 99.1, is being furnished and, as a result, such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such Section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$IMLFF to Present at the Small-Cap Stars Spring Conference 2015

InMed Pharmaceuticals Inc. (IMLFF) to Present at the Small-Cap Stars Spring Conference…

Namaste Technologies Inc. (NXTTF) Announces February 2018 Sales of C$1.37M Representing a 146% Year-Over-Year Increase

Namaste Announces February 2018 Sales of C$1.37M Representing a 146% Year-Over-Year Increase…

CLS Holdings USA, Inc. (CLSH) Announces November Results With Record Breaking Gross Profit Margin

Going Up: CLS Holdings USA, Inc. Announces November Results With Record Breaking…

Tetra Bio-Pharma Inc. (TBPMF) Receives Health Canada Approval for Phase 2 Cannabis Oil Trial

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial…